Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.

Authors

Bita Shakoory, George Washington University
Joseph A Carcillo
W Winn Chatham
Richard L. Amdur, George Washington UniversityFollow
Huaqing Zhao
Charles A Dinarello
Randall Q Cron
Steven M Opal

Document Type

Journal Article

Publication Date

2-1-2016

Journal

Critical Care Medicine

Volume

44

Issue

2

Inclusive Pages

275-281

DOI

10.1097/CCM.0000000000001402

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Shakoory, B., Carcillo, J.A., Chatham, W.W., Amdur, R.L., Zhao, H., ...Opal, S.M. (2016). Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Critical Care Medicine, 44(2), 275-281 7p. doi:10.1097/CCM.0000000000001402

Peer Reviewed

1

Open Access

1